Excelsior Medical Co Ltd
TWSE:4104
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (17.9), the stock would be worth NT$-85.22 (219% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -15 | NT$71.4 |
0%
|
| 3-Year Average | 17.9 | NT$-85.22 |
-219%
|
| 5-Year Average | 15.4 | NT$-73.27 |
-203%
|
| Industry Average | 12.9 | NT$-61.27 |
-186%
|
| Country Average | 19.4 | NT$-92.12 |
-229%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| TW |
E
|
Excelsior Medical Co Ltd
TWSE:4104
|
12.5B TWD | -15 | 15.5 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.1B USD | 12.5 | 23.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.1B USD | 19.7 | 36.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.5B USD | 19.8 | 36.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
46.1B USD | 6.8 | 27.7 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.3B AUD | 40.9 | 35.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 21.6 | 11.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 8.9 | 21.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.5B CNY | 136.2 | 20.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -236.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.6B HKD | -35.6 | 7.2 |
Market Distribution
| Min | 1.5 |
| 30th Percentile | 12.4 |
| Median | 19.4 |
| 70th Percentile | 33.6 |
| Max | 9 890.8 |
Other Multiples
Excelsior Medical Co Ltd
Glance View
Excelsior Medical Co. Ltd. engages in the sales and distribution of medical supplies and equipment, medicines and home medical devices. The company is headquartered in Taipei, New Taipei. The company went IPO on 2001-06-08. The Company’s principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The firm is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The firm mainly operates its businesses in domestic market and overseas markets.
